



Title: Gaining Synthetic Appreciation for the Gedunin ABC ring system
Authors: Craig McKenzie Williams, David Pinkerton, Timothy Vanden
Berg, and Paul Bernhardt
This manuscript has been accepted after peer review and appears as an
Accepted Article online prior to editing, proofing, and formal publication
of the final Version of Record (VoR). This work is currently citable by
using the Digital Object Identifier (DOI) given below. The VoR will be
published online in Early View as soon as possible and may be different
to this Accepted Article as a result of editing. Readers should obtain
the VoR from the journal website shown below when it is published
to ensure accuracy of information. The authors are responsible for the
content of this Accepted Article.
To be cited as: Chem. Eur. J. 10.1002/chem.201605751
Link to VoR: http://dx.doi.org/10.1002/chem.201605751





Gaining Synthetic Appreciation for the Gedunin ABC ring system 
David M. Pinkerton, Timothy J. Vanden Berg, Paul V. Bernhardt and Craig M. Williams*[a] 
Abstract: Gedunin, first isolated in 1960, displays a remarkable 
range of biological activity, but has yet to receive dedicated synthetic 
attention from a ground up construction perspective. Presented 
herein is a successfully executed approach to the fully-functionalized 
ABC ring system of this challengingly complex natural product. 
The tetranortriterpenoid gedunin (1), which was first isolated 
from the West African timber Entandrophragma angolense by 
Taylor in 1960,1-3 has been reported to exhibit antimalarial,4 
antifungal,5 allergic response,6 peptic ulcer,7 anti-cancer,8 
eryptosis,9 antifilarial,10 and insecticidal11 activity.12 In terms of 
anticancer activity, however, gedunin (1) was explored through 
the use of a connectivity map, and found to exert antiproliferative 
activity through the heat shock protein Hsp90.13 Gedunin (1) was 
later determined to interact with Hsp90 via a mechanism that 
does not involve competitive inhibition of ATP,14 and therefore, 
the interaction of gedunin (1) with Hsp90 was viewed as 
structurally and mechanistically distinct from that of other Hsp90 
active inhibitors.15 More recent work has indicated that 1 binds 
directly to the co-chaperone protein, p23, leading to inactivation 
of the Hsp90 machinery.16 Therefore, it is no surprise that 
gedunin (1) has attracted attention from medicinal chemists to 
potentially access unique Hsp90 modulatory ability for the 
treatment of cancer.17 
From a synthetic perspective, however, the majority of work in 
this area has been based on the derivitization of gedunin (1) 
itself, isolated from natural sources,17,18 although Fernández-
Mateos19 and Lhommet20 have used model systems to elegantly 
devise methods for the synthesis of the CDE ring system.21  
In the view that in-depth medicinal chemistry, tackling all points 
of skeletal change, will be required in the near future, and that 
no laboratory synthesis is currently available, we initiated an 
ambitious investigation into the total synthesis of 1. 
Retrosynthetically, we had initially hoped to incorporate aspects 
of our synthesis of mexicanolide (2),22 but it was soon realized 
these were not applicable and a new approach was required. 
Such steroidal systems usually invoke deployment of 
intramolecular Diels-Alder (IMDA)23 or polyene24 type 
cyclisations, but the C-7 acetate burdens these approaches. 
Thus, it was hard to avoid entertaining the multifaceted 
Robinson annulation,25 although incorporation of C-7 
functionality onto the B ring has not previously been explored in 
this context. On this premise, further retrosynthetic analysis 
would see opening of the D and E rings to give an advanced 
intermediate akin to alcohol 3, which would be derived from the 
key intermediate enone 4 (Scheme 1). Functionalisation of the B 
ring would most likely eventuate from tricycle 5, ultimately 
obtained from a methylated Wieland–Miescher ketone (i.e. 6), 
accessed via Robinson annulation of 2-methylcyclohexan-1,3-
dione (7). 
 
Scheme 1. Retrosynthetic analysis of gedunin (1) [P = protecting group]. 
Utilising the procedure described by Hanquet,26 reaction of dione 
7 with ethyl vinyl ketone (EVK) gave trione 8, which underwent a 
Robinson annulation catalyzed by L-phenylalanine. This afforded, 
after ketal protection, the enantio-enriched (ee 59%) methylated 
Wieland–Miescher ketone, obtained as the mono ketal protected 
surrogate (9) (Scheme 2). [Note: Although it was possible to 
procure enantiopure 9 via recrystallisation,26,27 we chose to 
focus on developing a route towards the ABC ring system of 
gedunin without incurring losses associated with enantio-
enrichment.] Annulation of 9 using a dissolving metal reduction, 
followed by conjugate addition and a Claisen condensation 
produced the target (10), via intermediate 11. This sequence, 
however, was both delicate and capricious, giving yields in the 
range of 10-86%, with most reaction yields matching that 
reported for related systems (i.e. ~30%).28 Nevertheless, this 
process was tolerated, because alternatives would substantially 
elongate the synthesis. 
 
Scheme 2. Second ring annulation giving the initial ABC ring system 
framework 10. 
Manipulation of the B ring was the pivotal challenge to our 
endeavour, as the majority of work on closely related systems 
have not required oxygenation on the B ring.21 Only in the case 
of Corey’s polyene derived azadiradione synthesis29 was a C-7 
hydroxyl group required and this was laboriously achieved 
through a Barton type C-H functionalisation strategy. With this in 
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mind, we adopted from steroid chemistry the well-known two-
step method for installing a B ring 6,7-double bond.30  
Treatment of 10 with acetic anhydride in the presence of acid 
gave the dienol (12) in 40% yield. Subsequent exposure of this 
compound to N-bromosuccinimide (NBS) and base smoothly 
converted it into the desired dienone 13 in 76% (Scheme 3). 
However, the newly formed γ,δ-double bond was surprisingly 
unreactive towards standard double bond functional group 
manipulation protocols. Finally, the powerful and compact 
oxidant dimethyl dioxirane (DMDO) was found to induce 
epoxidation. This level of forcing conditions lead to the formation 
of multiple oxidation products,31 which included, as the major 
product, the undesired 6β,7β-epoxide 14 in 39% yield (Scheme 
3). 
 
Scheme 3. Functionalisation of the B ring. 
Epoxide 15 and the diepoxide 16, obtained as minor products 
from the oxidation of dienone 13 with DMDO, provided crystals 
that were suitable for single-crystal X-ray analyses (Figure 1). 
Presumably, epoxidation of the A-ring was directed to the less-
encumbered α-face by the axial methyl group at C-10. However, 
epoxidation on the B-ring proceeded syn with respect to the 
axial B-ring methyl groups as evinced by the single-crystal X-ray 
structure of compound 15, and revealed by spectroscopic 
analysis of epoxide 14. This indicated that another structural 
feature may be overriding the normal mode of reactivity 
expected for compound 13. 
 
Figure 1 ORTEPs derived from single-crystal X-ray analyses of compounds 
15 (left) and 16 (right). Anisotropic displacement ellipsoids show 30% 
probability levels. 
Conformational assessment of 13 clearly showed that the 
dioxolane protecting group was substantially encumbering the α-
face, thereby impeding reagent approach from that direction. To 
overcome this problem, the ketal was hydrolyzed to afford 
diketone 17, which on subsequent epoxidation with DMDO gave 
the desired epoxide 18 as the major isomer in addition to a 
minor amount of the β-epoxide, 19 (Scheme 4). Cornered, with 
respect to working with an epoxide, it was thought advantageous 
to retain both ketones while enacting selective epoxide 
reduction. This requirement dramatically limited the range of 
suitable reductants. However, after extensively evaluating the 
reactivity of numerous systems (e.g. Al-Hg22c,32 and 
NaI/Na2SO333), only catalytic hydrogenation provided alcohol 20. 
This remarkable reduction, which will not proceed in the 
absence of triethylamine, is quantitative and occurs almost 
instantaneously (Scheme 4).34 Extending the duration of the 
reduction, however, led to the hydrogenation of the alkene in a 
process that was found to favour formation of the undesired 
isomer exhibiting cis-fusion at the AB ring junction. 
 
Scheme 4. Stereoselective epoxidation and reductive ring opening. 
Epoxides 18 and 19 were amenable to single-crystal X-ray 
analysis (Figure 2). The ORTEP diagrams were in accord with 
our stereochemical assignment of the epoxides and supported 
our hypothesis that removal of the dioxolane ring would restore 
conventional facial selectivity to reactions with the B-ring alkene. 
 
Figure 2 ORTEPs derived from single-crystal X-ray analyses of compounds 
18 (left) and 19 (right). Anisotropic displacement ellipsoids show 30% 
probability levels. 
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Poised for completion of the fully decorated ABC ring system of 
gedunin (1), several significant hurdles remained, specifically 
distinguishing between the two keto functions. Ultimately, 
success was achieved by engaging the C-7 hydroxyl in the 
formation of bis-ketal 21. Subjecting 21 to reduction by lithium in 
ammonia, followed by epimerisation with sodium methoxide, 
gave a slightly favourable ratio of desired ketone 22, which 
underwent smooth two-step A-ring oxidation to enone 24. The 
final stages of methylation and deprotection were unexpectedly 
difficult, but were finally overcome using potassium hydride and 
weakly acidic conditions, respectively. Subsequent acetylation of 
alcohol 25 proceeded efficiently and afforded the advanced 
intermediate (i.e. acetate 26) (Scheme 5). 
 
Scheme 5. Conversion of alcohol 20 into the fully decorated ABC ring system 
of gedunin (1), as embodied by acetate 26. 
In conclusion, an arduous synthetic campaign has secured the 
first route to the ABC ring system of gedunin (i.e. 26) and 
exposed some of the difficulties associated with assembling this 
motif. Accordingly, these challenges may well have contributed 
to the deficiency of published synthetic studies directed towards 
gedunin. It is expected that this work will strategically inform 
subsequent approaches towards a total synthesis of gedunin (1) 
and related limonoid natural products. Lastly, it is our hope that 
lessons learned in this campaign will assist future medicinal 
chemistry surrounding this biologically important molecule. 
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